36 related articles for article (PubMed ID: 2475487)
1. In vitro and in vivo properties of an anti-CD5-momordin immunotoxin on normal and neoplastic T lymphocytes.
Porro G; Bolognesi A; Caretto P; Gromo G; Lento P; Mistza G; Sciumbata T; Stirpe F; Modena D
Cancer Immunol Immunother; 1993 May; 36(5):346-50. PubMed ID: 7682894
[TBL] [Abstract][Full Text] [Related]
2. Immunoconjugate generation between the ribosome inactivating protein restrictocin and an anti-human breast carcinoma MAB.
Orlandi R; Canevari S; Conde FP; Leoni F; Mezzanzanica D; Ripamonti M; Colnaghi MI
Cancer Immunol Immunother; 1988; 26(2):114-20. PubMed ID: 3258791
[TBL] [Abstract][Full Text] [Related]
3. Selective toxicity of neocarzinostatin-monoclonal antibody conjugates to the antigen-bearing human melanoma cell line in vitro.
Lüders G; Köhnlein W; Sorg C; Brüggen J
Cancer Immunol Immunother; 1985; 20(1):85-90. PubMed ID: 2933140
[TBL] [Abstract][Full Text] [Related]
4.
Bisbal Lopez L; Ravazza D; Bocci M; Zana A; Principi L; Dakhel Plaza S; Galbiati A; Gilardoni E; Scheuermann J; Neri D; Pignataro L; Gennari C; Cazzamalli S; Dal Corso A
Front Pharmacol; 2023; 14():1320524. PubMed ID: 38125888
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in construction of small molecule-based fluorophore-drug conjugates.
Lang W; Yuan C; Zhu L; Du S; Qian L; Ge J; Yao SQ
J Pharm Anal; 2020 Oct; 10(5):434-443. PubMed ID: 33133727
[TBL] [Abstract][Full Text] [Related]
6. Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma.
Frankel AE; Woo JH; Ahn C; Foss FM; Duvic M; Neville PH; Neville DM
Haematologica; 2015 Jun; 100(6):794-800. PubMed ID: 25795722
[TBL] [Abstract][Full Text] [Related]
7. Immunotoxins: the role of the toxin.
Antignani A; Fitzgerald D
Toxins (Basel); 2013 Aug; 5(8):1486-502. PubMed ID: 23965432
[TBL] [Abstract][Full Text] [Related]
8. Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.
Pirie CM; Hackel BJ; Rosenblum MG; Wittrup KD
J Biol Chem; 2011 Feb; 286(6):4165-72. PubMed ID: 21138845
[TBL] [Abstract][Full Text] [Related]
9. Identification of a single amino acid substitution in the diphtheria toxin A chain of CRM 228 responsible for the loss of enzymatic activity.
Johnson VG; Nicholls PJ
J Bacteriol; 1994 Aug; 176(15):4766-9. PubMed ID: 8045910
[TBL] [Abstract][Full Text] [Related]
10. In vivo T-cell ablation by a holo-immunotoxin directed at human CD3.
Neville DM; Scharff J; Srinivasachar K
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2585-9. PubMed ID: 1372981
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of cellular trafficking and cytotoxicity of 9.2.27-gelonin immunotoxins targeted against the high-molecular-weight melanoma-associated antigen.
Chan MC; Murphy RM
Cancer Immunol Immunother; 1999 Feb; 47(6):321-9. PubMed ID: 10203062
[TBL] [Abstract][Full Text] [Related]
12. Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity.
Greenfield L; Johnson VG; Youle RJ
Science; 1987 Oct; 238(4826):536-9. PubMed ID: 3498987
[TBL] [Abstract][Full Text] [Related]
13. Mutations in diphtheria toxin to improve immunotoxin selectivity and understand toxin entry into cells.
Youle RJ
Semin Cell Biol; 1991 Feb; 2(1):39-45. PubMed ID: 1954342
[TBL] [Abstract][Full Text] [Related]
14. Diphtheria-related peptide hormone gene fusions: a molecular genetic approach to chimeric toxin development.
Murphy JR
Cancer Treat Res; 1988; 37():123-40. PubMed ID: 2908622
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of immunotoxin efficacy by acid-cleavable cross-linking agents utilizing diphtheria toxin and toxin mutants.
Neville DM; Srinivasachar K; Stone R; Scharff J
J Biol Chem; 1989 Sep; 264(25):14653-61. PubMed ID: 2475487
[TBL] [Abstract][Full Text] [Related]
16. Immunotoxin FN18-CRM9 induces stronger T cell signaling than unconjugated monoclonal antibody FN18.
Hamawy MM; Tsuchida M; Cho CS; Manthei ER; Fechner JH; Knechtle SJ
Transplantation; 2001 Aug; 72(3):496-503. PubMed ID: 11502982
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
